Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025

Darren L Dahly; Katie O’Brien; Lisa Domegan; Maureen O’Leary; Eva Kelly; Michael Hanrahan; Adele McKenna; Ajay Oza; Augustine Pereira; Éamonn O’Moore

doi:10.1101/2025.04.23.25326289

Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025

Darren L Dahly
, Katie O’Brien
, Lisa Domegan
, Maureen O’Leary
, Eva Kelly
, Michael Hanrahan
, Adele McKenna
, Ajay Oza
, Augustine Pereira
, Éamonn O’Moore

Research output: Other output

Original language	English
DOIs	https://doi.org/10.1101/2025.04.23.25326289
Publication status	Published - 25 Apr 2025

Access to Document

10.1101/2025.04.23.25326289

Cite this

Dahly, D. L., O’Brien, K., Domegan, L., O’Leary, M., Kelly, E., Hanrahan, M., McKenna, A., Oza, A., Pereira, A., & O’Moore, É. (2025, Apr 25). Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025. https://doi.org/10.1101/2025.04.23.25326289

@misc{74f3a442bc27419c8d7fe9eefa60a1b8,

title = "Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025",

author = "Dahly, \{Darren L\} and Katie O{\textquoteright}Brien and Lisa Domegan and Maureen O{\textquoteright}Leary and Eva Kelly and Michael Hanrahan and Adele McKenna and Ajay Oza and Augustine Pereira and {\'E}amonn O{\textquoteright}Moore",

year = "2025",

month = apr,

day = "25",

doi = "10.1101/2025.04.23.25326289",

language = "English",

type = "Other",

}

TY - GEN

T1 - Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025

AU - Dahly, Darren L

AU - O’Brien, Katie

AU - Domegan, Lisa

AU - O’Leary, Maureen

AU - Kelly, Eva

AU - Hanrahan, Michael

AU - McKenna, Adele

AU - Oza, Ajay

AU - Pereira, Augustine

AU - O’Moore, Éamonn

PY - 2025/4/25

Y1 - 2025/4/25

UR - https://doi.org/10.1101/2025.04.23.25326289

U2 - 10.1101/2025.04.23.25326289

DO - 10.1101/2025.04.23.25326289

M3 - Other output

ER -

Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025

Access to Document

Other files and links

Cite this